Skip to Content


Bulk Manufacturer of Controlled Substances Application: Pisgah Laboratories, Inc.

This document has a comment period that ends in 47 days. (05/26/2020) Submit a formal comment

Document Details

Information about this document as published in the Federal Register.

Document Statistics
Document page views are updated periodically throughout the day and are cumulative counts for this document including its time on Public Inspection. Counts are subject to sampling, reprocessing and revision (up or down) throughout the day.
Published Document

This document has been published in the Federal Register. Use the PDF linked in the document sidebar for the official electronic format.

Start Preamble


Notice of application.


Registered bulk manufacturers of the affected basic class(es), and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before May 26, 2020.


Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152.

End Preamble Start Supplemental Information


In accordance with 21 CFR 1301.33(a), this is notice that on February 3, 2020, Pisgah Laboratories, Inc., 3222 Old Hendersonville Highway, Pisgah Forest, North Carolina 28768 applied to be registered as a bulk manufacturer of the following basic class(es) of controlled substances:

Controlled substanceDrug codeSchedule
Meperidine intermediate-B9233II

The company plans to manufacture the above-listed controlled substances in bulk for distribution to its customers.

Start Signature

Dated: March 12, 2020.

William T. McDermott,

Assistant Administrator.

End Signature End Supplemental Information

[FR Doc. 2020-06168 Filed 3-23-20; 8:45 am]